Gilead Sciences Inc (GILD)

1,228.00 -4.00 (-0.32%)
Closed MXN Disclaimer

Gilead Sciences Inc Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
17000
Equity Type
ORD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Contact Information
Address
Foster City,94404 United States
Phone
650 574 3000
Fax
650 578 9264
Top Executives
Name
Age
Since
Title
Daniel P. O'Day 57 2019 Chairman & CEO
Paul Berg 96 1998 Member of Scientific Advisory Board
Grace E. Colon 56 2023 Chairman of the Board
Francis V. Chisari 0 0000 Member of the Scientific Advisory Board
Jacqueline K. Barton 70 1989 Independent Director
Kevin E. Lofton 68 2009 Lead Independent Director
Robert T. Schooley 0 0000 Member of the Scientific Advisory Board
Kenneth C. Anderson 72 0000 Member of the Scientific Advisory Board
Mark C. Genovese 0 0000 Member of Scientific Advisory Board
Eugene R. Schiff 0 0000 Member of the Scientific Advisory Board
John W. Mellors 85 0000 Member of the Scientific Advisory Board
Eric J. Topol 69 0000 Member of Scientific Advisory Board
Robert A. Harrington 62 0000 Member of the Scientific Advisory Board
Paul E. Klotman 0 0000 Member of the Scientific Advisory Board
Harish M. Manwani 70 2018 Independent Director
Javier J. Rodriguez 52 2020 Independent Director
Joel R. Huff 0 0000 Chairperson of Scientific Advisory Board
Malcolm MacCoss 75 0000 Member of Scientific Advisory Board
Kelly A. Kramer 55 2016 Independent Director
Nezam H. Afdhal 66 0000 Member of Scientific Advisory Board
Jeffrey A. Bluestone 70 2020 Independent Director
Sandra J. Horning 74 2020 Independent Director
Anthony Welters 68 2020 Independent Director
Ted W. Love 65 2024 Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.